Safety and Efficacy of Early Tube Removal Following Percutaneous Transhepatic Gallbladder Drainage: an Observational Study
Executive Summary
This briefing document synthesizes the findings of a large-scale retrospective observational study (n=701) regarding the timing and safety of drainage tube removal after Percutaneous Transhepatic Gallbladder Drainage (PTGBD) in patients with acute cholecystitis. While historical clinical practice often suggested a minimum of three weeks to allow for drainage track maturation, this study demonstrates that tube removal is safe and effective within a shorter period of 7 to 10 days, provided specific clinical and radiological criteria are met.
The study reports a low incidence of biliary peritonitis (0.7%) following planned tube removal and suggests that early removal can mitigate patient discomfort and risks associated with prolonged drainage, such as accidental tube dislodgement. These findings provide a data-driven basis for a new clinical management strategy for patients where early cholecystectomy is not indicated or available.
Background and Clinical Context
Acute Cholecystitis Management
Acute cholecystitis is a common inflammatory disease of the gallbladder. While early or urgent cholecystectomy is the standard for non-responsive cases, it carries a mortality rate of approximately 3.5% in elderly populations. For patients who are poor surgical candidates or where surgical intervention is unavailable, PTGBD is a widely recognized alternative.
The Role of PTGBD
Success Rates: PTGBD boasts a technical success rate of 100% and a low mortality rate (0% to 4%).
Tokyo Guidelines (TG13/TG18): These guidelines recommend PTGBD for various grades of cholecystitis, particularly when inflammation is uncontrolled, when negative predictive factors exist, or when advanced surgical facilities are unavailable.
The Clinical Gap: Despite established indications for PTGBD, existing guidelines do not provide specific recommendations regarding the advisability or optimal timing of tube removal. This study addresses the risks of prolonged drainage, including patient discomfort and accidental dislodgement.
Study Methodology and Patient Demographics
The study analyzed 701 patients treated between April 2014 and November 2017 across five medical centers in Japan.
Patient Profile
Mandatory Criteria for Tube Removal
Before a tube was removed, patients had to satisfy three specific conditions:
Subsiding Inflammation: Confirmed by decline in fever, normal white blood cell count, and resolution of abdominal pain.
Visible Duct Patency: Fluoroscopic imaging (cholecystostomy catheter with contrast) confirming visibility of the cystic duct and common bile duct.
Absence of Leakage: Confirmation via fluoroscopy that no intraperitoneal leakage was present.
Analysis of Clinical Outcomes
Planned Tube Removal
Tube removal was performed in 275 patients (39.2% of the cohort).
Timing: The median time until removal was 16 days.
Early Removal Success:
8 patients had tubes removed within 7 days.
35 patients had tubes removed within 10 days.
No biliary peritonitis was observed in any patient whose tube was removed within this 10-day window.
Complications: Only 2 patients (0.7%) developed biliary peritonitis after planned removal; notably, these occurred later (at 23 and 26 days).
Tube Dislodgement
Accidental dislodgement occurred in 82 patients (12.7%).
Median Time to Dislodgement: 12 days.
Risk Factors: Elderly patients were more likely to experience dislodgement, potentially due to delirium or dementia leading to accidental removal.
Management: 94% of dislodgement cases were managed conservatively with antibiotics and supportive care without the need for repeated PTGBD. Only 1.3% (1 patient) developed biliary peritonitis following dislodgement.
Cumulative Recurrence of Cholecystitis
Following tube removal, the cumulative rates of cholecystitis recurrence were:
30 Days: 3.4%
1 Year: 15.6%
3 Years: 25.4%
Discussion and Institutional Insights
Challenging the Track Maturation Paradigm
Historically, researchers argued that a minimum of 3 weeks (approximately 20 days) was necessary for the formation and maturation of a sealed drainage track to prevent bile leakage. This study challenges that standard, suggesting that if inflammation has subsided and ductal patency is confirmed, the track may not need 21 days to be functionally safe for tube removal.
Comparative Safety
The study highlights that its low complication rate may be attributed to:
Large Sample Size: Providing more robust data than previous smaller studies.
Feasibility Examinations: The rigorous use of the three predefined criteria (inflammation subsidence, duct patency, and no leakage) before removal.
Study Limitations
Retrospective Nature: The study did not confirm if early removal is safe for all patients, specifically those with chronic hepatitis or liver cirrhosis where fibrous adhesion and track maturation might be delayed.
Selection Bias: Only about 10% of cholecystitis patients are typically treated with PTGBD, potentially skewing the cohort toward higher-risk or elderly individuals.
Tube Variations: The study did not investigate whether tube diameter (7 Fr vs. 8 Fr) influenced removal safety.
Conclusions
The observational data indicates that PTGBD drainage tube removal is safe and effective after a short duration of 7 to 10 days, provided patients meet the criteria of subsided inflammation, patent bile ducts, and no intraperitoneal leakage. This findings support a shift toward shorter drainage periods, which may improve patient comfort and reduce the incidence of complications associated with prolonged catheterization. All observed cases of biliary peritonitis in the study were successfully treated with antibiotics, further reinforcing the safety profile of the procedure under the specified criteria.
